This article is available to subscribers. Subscribe now. Already have an account? Sign in

PerspectiveFree Preview

Institutionalizing Misinformation — The Dietary Supplement Listing Act of 2022

List of authors.
  • Pieter A. Cohen, M.D.,
  • Jerry Avorn, M.D.,
  • and Aaron S. Kesselheim, M.D., J.D., M.P.H.

A new bill, the Dietary Supplement Listing Act of 2022, would create the impression of reform in the supplement industry while leaving the current lax regulatory framework largely untouched.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available at NEJM.org.

This article was published on May 18, 2022, at NEJM.org.

Author Affiliations

From Cambridge Health Alliance, Somerville (P.A.C.), and Harvard Medical School (P.A.C., J.A., A.S.K.) and the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital (J.A., A.S.K.), Boston — all in Massachusetts.

Print Subscriber? Activate your online access.